Delivery Order SPE2DB24D2212-SPE2DB25FHQLQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,677.02 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries no set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $1,957.32 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. This competitive, non-set-aside award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a firm fixed-price transaction under a child delivery order structure. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,624.71 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes medication. This non-competitive, firm fixed-price delivery order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $2,381.85 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract was issued under a non-set-aside procurement and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $16,315.98 delivery order to AmerisourceBergen Drug Corp for 90-count bottles of Jardiance 25 mg tablets, a diabetes medication. This competitively awarded, firm fixed-price contract is classified as a delivery order under a larger indefinite delivery vehicle rather than a standalone agreement. The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and the pharmaceuticals will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,108.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract was competitively awarded without set-aside designation and has an ultimate completion date of August 11, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,691.02 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract was competitively awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16.7K to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, under firm fixed pricing with no set-aside designation. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.71 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. This non-competitive, firm fixed-price delivery order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a routine pharmaceutical supply delivery under...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQLQDelivery Order
The Defense Logistics Agency awarded a $24,339.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to the prime contractor. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, enabling AmerisourceBergen to deliver a broad range of medications, vaccines, medical devices, and related healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts demonstrates its critical role as a major distributor within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 8/4/25 |